R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Inspire Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inspire Medical Systems's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Inspire Medical Systems's R&D?
- Inspire Medical Systems (INSP) reported R&D of $25.83M in Q1 2026.
- How has Inspire Medical Systems's R&D changed year-over-year?
- Inspire Medical Systems's R&D decreased by 7.1% year-over-year, from $27.8M to $25.83M.
- What is the long-term trend for Inspire Medical Systems's R&D?
- Over 4 years (2021 to 2025), Inspire Medical Systems's R&D has grown at a 28.9% compound annual growth rate (CAGR), from $37.35M to $103.17M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.